KT-611 is primarily used in research settings for its potential immunomodulatory effects. It has been investigated for its ability to suppress T-cell activation, making it a candidate for studying autoimmune diseases and transplant rejection. The compound shows activity in inhibiting cytokine production, particularly interleukin-2 (IL-2), which plays a key role in immune response regulation. Due to this mechanism, KT-611 serves as a tool compound in pharmacological studies focused on immune system signaling pathways, especially those involving calcineurin inhibition. Its application remains limited to preclinical research, with no current use in clinical medicine.